highly significantP <0.01
Results: EECM produced a dose dependent anticonvulsant activity in both MES (by reducing the extensor phase of convulsions) and PTZ (by delaying the onset of convulsions) seizure models which was found to be highly significant ( P <0.01) with the optimal effect being observed at 200 mg/kg dose.